Associate director / head of pharmacodynamic unit
- Marburg, Universitätsstadt
stellenbeschreibung
Job Description About CSL Behring With operations in 35+ nations and ~ 20, 000 employees worldwide, CSL is driven to develop and deliver a broad range of lifesaving therapies to treat disorders such as hemophilia and primary immune deficiencies, and vaccines to prevent influenza. Our therapies are also used in cardiac surgery, organ transplantation and burn treatment. CSL is the parent company of CSL Behring and Seqirus. CSL Behring is a global leader in the protein biotherapeutics industry, focused on bringing to market biotherapies used to treat serious and often rare conditions. CSL Behring operates CSL Plasma, one of the world's largest collectors of human plasma, which is used to create CSL's therapies. Seqirus is the second largest influenza vaccine company in the world and is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally. We invite you to take a look at the many career possibilities available around the globe and consider building your promising future at CSL by becoming a member of our team! For our Pharmacology & Toxicology department we are looking for a Associate Director / Head of Pharmacodynamic Unit (m/f/x) - R-111486 (fulltime / permanent / non-tariff) Job Purpose The Head of Pharmacodynamic (PD) Unit will have operational leadership and responsibility for preclinical Research and Development (R&D) activities undertaken within her/his unit for which she/he will provide scientific expertise and managerial guidance. These R&D activities will focus primarily on the 5 CSL therapeutic areas (Hematology Immunology Transplantation, Cardiovascular Respiratory) and 3 CSL's therapeutic platforms (plasma products;recombinant products;
gene therapy approaches), and will encompass activities relevant to both existing CSL products and new product candidates. Thereby, the incumbent guides and has responsibility over a team of (senior) scientists (including their respective sub-teams). The Head of the PD Unit will lead and manage her/his unit as a center of excellence to support CSL projects with pharmacological expertise and capability. The incumbent and her/his team are responsible to design, manage, execute and report preclinical pharmacological efficacy studies (in vivo, ex vivo and in vitro) from proof of concept to dose-response and Pharmacokinetic (PK)/PD assessments for CSL R&D projects / products as required to enable and continuously support clinical development, global licensing and marketing. The Head of the PD Unit works in close collaboration with other Pharmacology & Toxicology units and relevant associated functions across global R&D (and beyond) to set project objectives and to determine, implement and execute on scientific and technical project strategies. The incumbent will moreover actively participate in CSL's innovation by identifying and evaluating new product opportunities. - As Head of the PD Unit, the incumbent leads a group of skilled (senior) scientists (including sub-teams), and will plan, resource and execute tasks within her/his unit. The incumbent will define and implement appropriate organizational structures (in consultation with the Head of Marburg PHT, as appropriate) and will recruit, develop, coach and motivate staff within her/his unit. The incumbent will be responsible for adequate qualification and training within her/his unit. - The incumbent will oversee and actively participate in the design and execution of preclinical PD Unit studies and project objectives, delegate tasks and projects, and plan and monitor adherence to budget consistent with agreed overall project objectives and timelines, and taking into account project prioritization as determined by the Research Portfolio Management Committee (RPMC) and/or Therapeutic Area Leadership Teams (TALTs). Within her/his unit, the incumbent will ensure the application of state-of-the-art concepts and methodologies in respect of scientific and regulatory issues. - The incumbent will be responsible for planning and execution of assigned pharmacological studies (internal and external;
in vivo, ex vivo and invitro) according to regulatory/internal guidelines and quality standards in English/German as required and will manage the preparation and review of documents / reports / publications / presentations to support R&D, product licensing, regulatory submissions, patents & licenses and marketing. - The incumbent will ensure that relevant quality & health, environmental & safety and animal health & welfare standards are applied and that appropriate staffing, space and qualified equipment are established and available as required. - The incumbent will contribute to the development and management of an external preclinical pharmacology research network via collaboration with both academic groups and contract research organizations. This will include the management of and, as appropriate, contribution to project ideas, and th
Bewerben Sie sich jetzt um
Associate director / head of pharmacodynamic unit (m/f/x)Sie werden auf eine andere Website weitergeleitet.
jetzt anmelden
Seien Sie der Erste, der neue Stellenangebote erhält
Mein Stellen-Alarm
Ihr Alarm wurde Ihrer Seite
Mein Stellen-Alarm
hinzugefügt.
Ihre Bestätigung steht noch aus,
gehen Sie bitte zu Ihrem E-Mail-Posteingang
und klicken Sie auf den Bestätigungslink, den wir Ihnen gesendet haben
mehr...
zur Vakanz
Weitere Jobs von Csl Behring Gmbh